Gliatech To Submit Third-Party Audit Data To FDA In The Third Quarter
This article was originally published in The Gray Sheet
Executive Summary
Gliatech remains on schedule to submit an independent clinical study site audit report in the third quarter related to its Adcon-L gel anti-adhesion product for lumbar surgery, the firm says.